Germany's BioNTech said on Monday it is entering into a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of its mpox vaccine. CEPI will provide funding of up to $90 million to support the development of vaccine candidates which is based on BioNTech's mRNA technology.
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles